Clinical Research
Keeping in line with it’s commitment to

advances and innovation in medicine

Keeping in line with our commitment to advancing the medical field and promoting innovation in the sector, Bellevue participates in the conduct of research in various branches of medicine. Research studies undergo a thorough approval process conducted by a dedicated committee of professionals responsible for the promotion and facilitation of ethical clinical research.

You may find below a list of clinical research trials that are currently ongoing at Bellevue.

Condition/Illness Related Research
Brief Summary Bellevue Medical
Center Investigator
Absolute Uterine Factor Infertility NCT01844362 Interventional clinical trial to assess if a uterus transplanted from a live donor can result in a successful pregnancy. read more Dr. Joseph Abboud
Dr. Abdo Waked
Dr. Pascal Hajj
Dr. Toufic Nakad
Advanced breast cancer CLEE011A2301 (Monaleesa 2) Randomized study for post-menopause women with no prior treatment. Dr. Fadi El Karak
Metastatic non-small cell lung cancer (NSCLC) CLDK378A2112 Randomized study for adults to compare efficacy and safety of treatment taken with different diets. Dr. Fadi El Karak
Relapsed or relapsed/refractory multiple myeloma CLBH589D2222 (PANORAMA 3) Randomized study for patients previously exposed to immune-modulatory agents to evaluate the safety and efficacy of 3 different regimens. Dr. Fadi El Karak
Advanced breast cancer CLEE011A2404 (COMPLEEMENT-1) Study to assess safety and efficacy of a hormonal therapy regimen in men and women with no prior hormonal therapy. Dr. Fadi El Karak
Chronic immune thrombocytopenia CETB115BIC02 (CITE) Observational studyto evaluate treatment with Revolade. Dr. Fadi El Karak
Advanced renal cell carcinoma CPZP034AIC04 (PARACHUTE) Prospective, non-interventional, observational study to assess past treatment. Dr. Fadi El Karak
Breast cancer CBYL719A2201 Randomized study to assess 2 different treatments in postmenopausal women. Dr. Dany Abi Gerges
Chronic myelogenous leukemia CABL001A2301 Randomized study for patients previously treated with 2 or more tyrosine kinase inhibitors. Dr. Dany Abi Gerges
Advanced or metastatic non-small cell lung cancer (NSCLC) TAIL study Study to explore long-term safety and efficacy of an immunotherapy treatment in patients previously treated. Dr. Fadi El Karak
Type 2 diabetes LIRA PRIME Study to assess safety and efficacy of different treatments on top of metformin in patients with poorly controlled diabetes on metformin alone. Dr. Grace Abi Rizk
Type 2 diabetes SUSTAIN 8 Study to compare safety and efficacy of 2 different treatments on top of metformin. Dr. Georges Hajj
Acute heart failure AFFIRM-AHF Randomized study to compare safety, efficacy and outcomes of a new treatment vs. placebo in patients with iron deficiency anemia. Dr. Ghassan Kiwan
Venous thromboembolism (VTE) Deep vein thrombosis (DVT) Pulmonary embolism (PE) RE-COVERY Study to follow outcomes and compare safety and efficacy of a new vs. traditional treatment in preventing DVTs and PEs. Dr. Ghassan Kiwan
Migraine EmPOWER Randomized study for adults comparing safety and efficacy of subcutaneous treatment vs. placebo. Dr. Souheil Gbeily
Metastatic colorectal cancer (mCRC) OPTIMISE Observational study to assess treatment. Dr. Fadi El Karak